Pediatric fibroblastic/myofibroblastic tumors are rare but include a wide variety of benign to malignant tumors. Given their uncommon frequency, they may present as a diagnostic dilemma. This article is focused on using clinical and pathologic clues in conjunction with the increasingly relevant and available molecular techniques to classify, predict prognosis, and/or guide treatment in these tumors.
- Infantile fibrosarcoma
- Nodular fasciitis
- Receptor tyrosine kinases
ASJC Scopus subject areas
- Pathology and Forensic Medicine